Opinion: Archaea Is Our Evolutionary Sister, Not Mother

The ancient organisms appear to be more closely related to eukaryotes than previously appreciated.

Written byMorgan Gaia, Violette Da Cunha, and Patrick Forterre
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

© ISTOCK.COM/NANOSTOCKKIn 1977, biologist Carl Woese discovered that microbes living in anaerobic conditions and producing methane had a genetic imprint very different from known bacteria species. He and his colleagues eventually suggested that researchers stop referring to such methanogens and related microorganisms as bacteria, classifying them instead as members of a new domain in a tripartite division of the living world, alongside Bacteria and Eukarya.

Woese named this domain Archaea (from the Greek archaio, meaning ancient or original) because the microbes he studied seemed to thrive in extreme conditions akin to those of early Earth. Later on, scientists observed archaea in more-diverse environments, from oceanic water and deep sediments to forest soil and the surface of human skin. Recently, a new archaeal group named after its discoverer, Woesearchaeota, was even detected in human lungs. Although archaea superficially resemble bacteria in terms of size and cellular organization (members of both groups lack nuclei), they are surprisingly similar to eukaryotes at the molecular level. For instance, all archaea replicate their DNA and synthesize proteins using molecular machines like those of eukaryotes. This suggests that Eukarya and Archaea belong to a same “super-domain” ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

June 2018

Microbial Treasure

Newly discovered archaea reveal bizarre biology

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies